Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma.

Eppinga RD, Krueger EW, Weller SG, Zhang L, Cao H, McNiven MA.

Oncogene. 2012 Mar 8;31(10):1228-41. doi: 10.1038/onc.2011.329. Epub 2011 Aug 15.

2.

Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.

Razidlo GL, Wang Y, Chen J, Krueger EW, Billadeau DD, McNiven MA.

Dev Cell. 2013 Mar 25;24(6):573-85. doi: 10.1016/j.devcel.2013.02.010.

3.

Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion.

Feng H, Liu KW, Guo P, Zhang P, Cheng T, McNiven MA, Johnson GR, Hu B, Cheng SY.

Oncogene. 2012 May 24;31(21):2691-702. doi: 10.1038/onc.2011.436. Epub 2011 Sep 26.

4.

Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.

Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K.

Cancer Res. 2006 Nov 1;66(21):10525-33.

5.

Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.

Unruh D, Turner K, Srinivasan R, Kocatürk B, Qi X, Chu Z, Aronow BJ, Plas DR, Gallo CA, Kalthoff H, Kirchhofer D, Ruf W, Ahmad SA, Lucas FV, Versteeg HH, Bogdanov VY.

Int J Cancer. 2014 Jan 1;134(1):9-20. doi: 10.1002/ijc.28327. Epub 2013 Jul 27.

6.

Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2.

Weller SG, Capitani M, Cao H, Micaroni M, Luini A, Sallese M, McNiven MA.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5863-8. doi: 10.1073/pnas.0915123107. Epub 2010 Mar 15.

7.

A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.

Paladino D, Yue P, Furuya H, Acoba J, Rosser CJ, Turkson J.

Oncotarget. 2016 Feb 9;7(6):7253-67. doi: 10.18632/oncotarget.6635.

8.

Quantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex.

Kawahara T, Hotta N, Ozawa Y, Kato S, Kano K, Yokoyama Y, Nagino M, Takahashi T, Yanagisawa K.

PLoS One. 2013 Dec 5;8(12):e79654. doi: 10.1371/journal.pone.0079654. eCollection 2013.

9.

The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.

Xu B, Teng LH, Silva SD, Bijian K, Al Bashir S, Jie S, Dolph M, Alaoui-Jamali MA, Bismar TA.

Cancer Med. 2014 Feb;3(1):14-24. doi: 10.1002/cam4.168. Epub 2013 Dec 18.

10.

Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.

Morton JP, Karim SA, Graham K, Timpson P, Jamieson N, Athineos D, Doyle B, McKay C, Heung MY, Oien KA, Frame MC, Evans TR, Sansom OJ, Brunton VG.

Gastroenterology. 2010 Jul;139(1):292-303. doi: 10.1053/j.gastro.2010.03.034. Epub 2010 Mar 17.

PMID:
20303350
11.

SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer.

Gao Z, Zhang J, Bi M, Han X, Han Z, Wang H, Ou Y.

Int J Clin Exp Pathol. 2015 May 1;8(5):4791-8. eCollection 2015.

12.

The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.

Muniz VP, Barnes JM, Paliwal S, Zhang X, Tang X, Chen S, Zamba KD, Cullen JJ, Meyerholz DK, Meyers S, Davis JN, Grossman SR, Henry MD, Quelle DE.

Mol Cancer Res. 2011 Jul;9(7):867-77. doi: 10.1158/1541-7786.MCR-10-0475. Epub 2011 Jun 2.

13.

Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.

Arumugam T, Brandt W, Ramachandran V, Moore TT, Wang H, May FE, Westley BR, Hwang RF, Logsdon CD.

Pancreas. 2011 Aug;40(6):815-22. doi: 10.1097/MPA.0b013e31821f6927.

14.

Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.

Ueda J, Matsuda Y, Yamahatsu K, Uchida E, Naito Z, Korc M, Ishiwata T.

Oncogene. 2014 Sep 4;33(36):4485-95. doi: 10.1038/onc.2013.392. Epub 2013 Sep 30.

15.

Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.

Zimmerman NP, Roy I, Hauser AD, Wilson JM, Williams CL, Dwinell MB.

Mol Carcinog. 2015 Mar;54(3):203-15. doi: 10.1002/mc.22091. Epub 2013 Sep 24.

16.

Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.

Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B.

Int J Cancer. 2012 Aug 15;131(4):E371-81. doi: 10.1002/ijc.26502. Epub 2012 Jan 11.

17.

LRH1 promotes pancreatic cancer metastasis.

Lin Q, Aihara A, Chung W, Li Y, Chen X, Huang Z, Weng S, Carlson RI, Nadolny C, Wands JR, Dong X.

Cancer Lett. 2014 Aug 1;350(1-2):15-24. doi: 10.1016/j.canlet.2014.04.017. Epub 2014 Apr 24.

PMID:
24769073
18.

A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma.

Sun YW, Chen YF, Li J, Huo YM, Liu DJ, Hua R, Zhang JF, Liu W, Yang JY, Fu XL, Yan T, Hong J, Cao H.

Br J Cancer. 2014 Nov 25;111(11):2131-41. doi: 10.1038/bjc.2014.520. Epub 2014 Oct 14.

19.

Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.

Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y, Liu QH, Shi M, Ni CR, Zhu MH.

Oncol Rep. 2014 Mar;31(3):1157-64. doi: 10.3892/or.2013.2960. Epub 2013 Dec 31.

PMID:
24398877
20.

Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.

Dallas NA, Gray MJ, Xia L, Fan F, van Buren G 2nd, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LM.

Clin Cancer Res. 2008 Dec 15;14(24):8052-60. doi: 10.1158/1078-0432.CCR-08-1520.

Supplemental Content

Support Center